Published on Dec 14, 2012
Professor Foster considers the implications of starting treatment now versus deferring for possible future therapies.
This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
No comments:
Post a Comment